Pictor Labs

Pictor Labs

Pathology & Laboratory Diagnostics

About Pictor Labs

Pictor Labs is a virtual staining technology company that replaces traditional chemical staining with AI-powered digital staining for pathology and laboratory diagnostics. The company's platform generates diagnostic-quality virtual stains including H&E, IHC, and special stains in minutes rather than hours or days, while preserving tissue samples for downstream analysis. Pictor Labs offers three core products: ClearStain™ for direct virtual H&E generation from unstained slides for molecular testing workflows, DeepStain™ for virtual histological staining from label-free tissue using autofluorescence imaging, and ReStain for virtual re-staining of existing H&E images. The technology is trained on expertly curated, co-registered image pairs and provides consistent, high-quality visualization across multiple laboratory sites. The platform integrates into existing workflows with flexible deployment options including cloud and on-premise environments, and is compatible with leading scanner platforms. Pictor Labs serves biopharma companies, contract research organizations (CROs), academic medical centers, and veterinary pathology labs. The company's technology addresses critical workflow challenges including tissue preservation, turnaround time reduction, staining consistency across sites, and maximizing analytical insight from limited biopsy material. Currently offered for research use only (RUO), the virtual staining outputs are reviewed by qualified pathologists and designed to support visualization and workflow flexibility rather than replace medical expertise.

Mission & Story

Founding Story

Led by CEO and Co-Founder Yair Rivenson, PhD, and Co-Founder Aydogan Ozcan, the company was established to modernize pathology workflows through AI-powered virtual staining technology.

Clinical Focus

Medical conditions and clinical areas addressed by Pictor Labs.

Classic Hodgkin lymphomaLymphomasLung carcinomasCancer researchTumor microenvironment analysis

Who It Serves

Biopharma companiesContract Research Organizations (CROs)Academic medical centersVeterinary pathology labsResearch institutions

Milestones & Awards

Recent Milestones

Presented research at SITC 2024, AACR 2024, and USCAP 2024. Deployed with leading biopharma companies, CROs, and academic medical centers for real-world workflow integration.

Key Partnerships

Leica BiosystemsUniversity of MarylandJohns HopkinsUCLA

Social & Media

Follow on

Company Details

Employees
1-10

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Official Sources

Last updated Jul 1, 2026

Similar Companies in this Market

View all 45
Aiforia

Aiforia

Aiforia provides AI-powered digital pathology solutions for clinical diagnostics and research. The company offers cloud-based deep learning tools and CE-IVD marked clinical suites for analyzing pathology images across multiple cancer types, serving pathologists, researchers, and diagnostic laboratories worldwide.

Aignostics

Aignostics

Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.

Aiosyn

Aiosyn

Aiosyn develops AI-powered computational pathology software that integrates into standard digital pathology workflows. The company specializes in deep learning solutions for cancer and chronic kidney disease diagnostics, serving clinical laboratories, biopharma, and CROs.

AIxMed

AIxMed

AIxMed develops AI-powered computational cytology platforms for cancer detection and diagnosis. The company's flagship product AIxURO analyzes urine cytology for bladder cancer, with additional platforms in development for thyroid, cervical, and lung cancer screening.

Akoya Biosciences

Akoya Biosciences

Akoya Biosciences, now part of Quanterix, provides spatial biology solutions for high-plex tissue analysis. The company develops instruments, assays, and software for spatial proteomics research, enabling researchers to map biomarkers at single-cell resolution in tissue samples.

Caris Life Sciences

Caris Life Sciences

Caris Life Sciences is a leading precision medicine company that provides comprehensive molecular profiling for cancer patients. The company combines genomic, transcriptomic, and proteomic data with AI to deliver personalized treatment insights for oncologists and patients.

CellaVision

CellaVision

201-500 employees

CellaVision is a world-leading provider of digital hematology microscopy solutions covering analyzers, instruments, reagents, and software. The company automates workflows in hematology laboratories of all sizes for human and animal blood and body fluid sample analysis.

Clever Culture Systems

Clever Culture Systems

Clever Culture Systems develops AI-powered automated microbiology culture plate reading technology for pharmaceutical and clinical laboratories. Their flagship product, APAS Independence, automates the imaging, interpretation, and reporting of microbial growth on culture plates.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.